Specialty and community pharmacies play an essential role in the 340B program and must be protected against interference by drug [...] …
Category: Providers
Pharmaceutical manufacturer Merck has announced it will refund 340B covered entities for certain overcharges of its inhaler, Proventil HFA, during [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The new industry vendor administrating Johnson & Johnson’s (J&J’s) contested 340B rebate proposal is hosting an in-person training for third [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
German drugmaker Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy beginning Oct. 1—the same day [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Certain formulations for four of the first ten drugs selected for Medicare drug price negotiations have newly negotiated prices lower [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Boston-based biopharmaceutical company will soon extend its contract pharmacy restrictions from hospitals to all 340B covered entities (CEs), except [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major hospital advocacy groups are urging the federal agency that oversees the 340B program to “take immediate enforcement action” [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B program’s growth in recent decades has helped it attract a growing number of corporate and private equity investments, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmakers Sanofi and Sumitoma Pharma America (SMPA) each announced they are partially exempting Missouri-based providers from their contract pharmacy restrictions [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Johnson & Johnson’s (J&J’s) proposed 340B rebate model, which has not received government approval, would give the drugmaker significantly more [...] …